Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373822

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373822

Global Pediatric Healthcare Market Size, Share, Growth Analysis, By Type(Chronic and acute), By Treatment(Vaccines, drugs and others) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Pediatric Healthcare Market size was valued at USD 12 billion in 2021 and is poised to grow from USD 12.53 billion in 2022 to USD 17.68 billion by 2030, growing at a CAGR of 4.4% during the forecast period (2023-2030).

The global pediatric healthcare market is a dynamic and rapidly expanding sector dedicated to the well-being of children. It is fueled by factors like technological advancements, increased healthcare spending, and a growing emphasis on preventive care, all driven by a rising global population and growing awareness of pediatric health issues. This market encompasses various segments, including diagnostics, therapeutics, vaccines, medical devices, and support services. Diagnostic services focus on early detection and accurate diagnosis, therapeutics cater to children's unique healthcare needs, vaccines are vital for disease prevention, medical devices range from basic tools to surgical instruments, and support services include hospitals, clinics, and home healthcare providers. Competition is fierce, with multinational companies, regional players, and startups competing for market share through R&D, collaborations, mergers, acquisitions, and product launches.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pediatric healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Global Pediatric Healthcare Market is segmented by type, treatment, and region. Based on type, the market can be segmented into chronic and acute. Based on treatment, the market is segmented into Vaccines, drugs and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Increasing awareness and emphasis on preventive care

A significant catalyst propelling the global pediatric healthcare market is the heightened awareness and focus on preventive healthcare, underpinned by the recognition of the vital role early detection, timely interventions, and preventive measures play in pediatric well-being. This surge in emphasis stems from the collective aspiration to mitigate the enduring effects of pediatric ailments and enhance children's overall health. Consequently, preventive healthcare initiatives such as regular check-ups, vaccinations, and screenings are being prioritized to promptly identify and manage potential health concerns.

Restraints:

High cost associated with pediatric healthcare services and treatments

A major challenge facing the global pediatric healthcare market is the substantial expense associated with pediatric healthcare services and treatments. Delivering specialized care for children involves costly elements such as advanced technologies, specialized medications, and the necessity for healthcare professionals possessing expertise in pediatric care. The financial burden of pediatric healthcare can be particularly burdensome for families, particularly in areas lacking affordable healthcare options or sufficient insurance coverage. This financial barrier restricts some children's access to high-quality care, resulting in healthcare disparities and somewhat impeding market expansion. To ensure fair access to pediatric healthcare, it is crucial to make concerted efforts in addressing cost-related issues and enhancing affordability.

Market Trends:

A notable market trend in the global pediatric healthcare sector is the growing emphasis on personalized and precision medicine for young patients. This trend is gaining traction as healthcare professionals and researchers acknowledge the distinctive physiological, genetic, and developmental characteristics of children. Progress in technologies like genomics, molecular diagnostics, and biomarker identification is facilitating a more precise and tailored approach to pediatric healthcare, aiming to enhance treatment efficacy, reduce side effects, and improve overall patient well-being by taking into account the unique biological and genetic diversity among pediatric populations.

Product Code: SQMIG35I2175

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Pediatric Healthcare Market by Type
    • Market Overview
    • Chronic and acute
  • Global Pediatric Healthcare Market by Treatment
    • Market Overview
    • Vaccines
    • drugs and others
  • Global Pediatric Healthcare Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • The Procter & Gamble Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eli Lilly and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bristol-Myers Squibb Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Shire (Republic of Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Gilead Sciences, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mylan N.V. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!